Dunedin cancer diagnostic company Pacific Edge Ltd has signalled its intention to list on the Australian Stock Exchange (ASX). In an announcement to the New Zealand Stock Exchange (NZX) this morning, the company said it would file an application today with the ASX to dual list as a Foreign Exempt Entity. Pacific Edge first listed on the NZX in 2003 and that would remain its primary listing. Pacific Edge's NZX share price was trading at around $1.410 this morning, up from $1.340 on Friday. The ASX has given its approval in principle and Pacific Edge expects to be dual listed by the end of the September.

Source: Otago Daily Times August 29, 2021 22:52 UTC